These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
386 related articles for article (PubMed ID: 21395514)
41. Long circulating chitosan/PEG blended PLGA nanoparticle for tumor drug delivery. Parveen S; Sahoo SK Eur J Pharmacol; 2011 Nov; 670(2-3):372-83. PubMed ID: 21951969 [TBL] [Abstract][Full Text] [Related]
42. A short appraisal of polylactic-co-glycolic acid based polymer nanotechnology for colon cancer: recent advances and literature evidences. Vashishat A; Singh A; Kurmi BD; Gupta GD; Singh D Ther Deliv; 2023 Jul; 14(7):459-472. PubMed ID: 37559461 [TBL] [Abstract][Full Text] [Related]
43. Biodegradable nanoparticles sequentially decorated with Polyethyleneimine and Hyaluronan for the targeted delivery of docetaxel to airway cancer cells. Maiolino S; Russo A; Pagliara V; Conte C; Ungaro F; Russo G; Quaglia F J Nanobiotechnology; 2015 Apr; 13():29. PubMed ID: 25888948 [TBL] [Abstract][Full Text] [Related]
44. Poly aspartic acid peptide-linked PLGA based nanoscale particles: potential for bone-targeting drug delivery applications. Jiang T; Yu X; Carbone EJ; Nelson C; Kan HM; Lo KW Int J Pharm; 2014 Nov; 475(1-2):547-57. PubMed ID: 25194353 [TBL] [Abstract][Full Text] [Related]
45. Aptamer-conjugated PLGA nanoparticles for delivery and imaging of cancer therapeutic drugs. Hashemi M; Shamshiri A; Saeedi M; Tayebi L; Yazdian-Robati R Arch Biochem Biophys; 2020 Sep; 691():108485. PubMed ID: 32712288 [TBL] [Abstract][Full Text] [Related]
46. Ultrasound-guided delivery of microRNA loaded nanoparticles into cancer. Wang TY; Choe JW; Pu K; Devulapally R; Bachawal S; Machtaler S; Chowdhury SM; Luong R; Tian L; Khuri-Yakub B; Rao J; Paulmurugan R; Willmann JK J Control Release; 2015 Apr; 203():99-108. PubMed ID: 25687306 [TBL] [Abstract][Full Text] [Related]
47. Uniform carboxymethyl chitosan-enveloped Pluronic F68/poly(lactic-co-glycolic acid) nano-vehicles for facilitated oral delivery of gefitinib, a poorly soluble antitumor compound. Wang J; Wang F; Li X; Zhou Y; Wang H; Zhang Y Colloids Surf B Biointerfaces; 2019 May; 177():425-432. PubMed ID: 30798063 [TBL] [Abstract][Full Text] [Related]
48. A cell-targeted chemotherapeutic nanomedicine strategy for oral squamous cell carcinoma therapy. Wang ZQ; Liu K; Huo ZJ; Li XC; Wang M; Liu P; Pang B; Wang SJ J Nanobiotechnology; 2015 Oct; 13():63. PubMed ID: 26427800 [TBL] [Abstract][Full Text] [Related]
49. Comparison of sorafenib-loaded poly (lactic/glycolic) acid and DPPC liposome nanoparticles in the in vitro treatment of renal cell carcinoma. Liu J; Boonkaew B; Arora J; Mandava SH; Maddox MM; Chava S; Callaghan C; He J; Dash S; John VT; Lee BR J Pharm Sci; 2015 Mar; 104(3):1187-96. PubMed ID: 25573425 [TBL] [Abstract][Full Text] [Related]
51. Comparative study of superparamagnetic iron oxide/doxorubicin co-loaded poly (lactic-co-glycolic acid) nanospheres prepared by different emulsion solvent evaporation methods. Mosafer J; Teymouri M Artif Cells Nanomed Biotechnol; 2018 Sep; 46(6):1146-1155. PubMed ID: 28789586 [TBL] [Abstract][Full Text] [Related]
52. Targeted and controlled drug delivery system loading artersunate for effective chemotherapy on CD44 overexpressing cancer cells. Tran TH; Nguyen TD; Van Nguyen H; Nguyen HT; Kim JO; Yong CS; Nguyen CN Arch Pharm Res; 2016 May; 39(5):687-94. PubMed ID: 27015824 [TBL] [Abstract][Full Text] [Related]
53. Development and optimization of doxorubicin loaded poly(lactic-co-glycolic acid) nanobubbles for drug delivery into HeLa cells. Deng L; Li L; Yang H; Li L; Zhao F; Wu C; Liu Y J Nanosci Nanotechnol; 2014 Apr; 14(4):2947-54. PubMed ID: 24734715 [TBL] [Abstract][Full Text] [Related]
54. Engineered PLGA nano- and micro-carriers for pulmonary delivery: challenges and promises. Ungaro F; d'Angelo I; Miro A; La Rotonda MI; Quaglia F J Pharm Pharmacol; 2012 Sep; 64(9):1217-35. PubMed ID: 22881435 [TBL] [Abstract][Full Text] [Related]
55. Prevention of Oxidized Low Density Lipoprotein-Induced Endothelial Cell Injury by DA-PLGA-PEG-cRGD Nanoparticles Combined with Ultrasound. Li Z; Huang H; Huang L; Du L; Sun Y; Duan Y Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28406431 [TBL] [Abstract][Full Text] [Related]
56. Poly(D,L-lactide-co-glycolide) nanoparticles encapsulated fluorescent isothiocyanate and paclitaxol: preparation, release kinetics and anticancer effect. Yang H; Li K; Liu Y; Liu Z; Miyoshi H J Nanosci Nanotechnol; 2009 Jan; 9(1):282-7. PubMed ID: 19441308 [TBL] [Abstract][Full Text] [Related]
57. High glycolic poly (DL lactic co glycolic acid) nanoparticles for controlled release of meropenem. Nandakumar V; Geetha V; Chittaranjan S; Doble M Biomed Pharmacother; 2013 Jun; 67(5):431-6. PubMed ID: 23583192 [TBL] [Abstract][Full Text] [Related]
58. Surface modification of PLGA nanoparticles by carbopol to enhance mucoadhesion and cell internalization. Surassmo S; Saengkrit N; Ruktanonchai UR; Suktham K; Woramongkolchai N; Wutikhun T; Puttipipatkhachorn S Colloids Surf B Biointerfaces; 2015 Jun; 130():229-36. PubMed ID: 25937384 [TBL] [Abstract][Full Text] [Related]
59. Chitosan-modified PLGA nanoparticles tagged with 5TR1 aptamer for in vivo tumor-targeted drug delivery. Taghavi S; Ramezani M; Alibolandi M; Abnous K; Taghdisi SM Cancer Lett; 2017 Aug; 400():1-8. PubMed ID: 28412238 [TBL] [Abstract][Full Text] [Related]